Autoimmune Glomerulonephritis Wistar: Van Dixhoorn MGA, Sato T, Muizert Y, Van Gijlswijk-Janssen DJ, De Heer E, Daha MR. Combined glomerular deposition of polymeric rat IgA and IgG aggravates renal inflammation. Kidney International 58: (1) 90-99 JUL 2000. BN: Escudero E, Martin A, Nieto M, Nieto E, Navarro E, Luque A, Cabanas C, Sanchez-Madrid F, Mampaso F. Functional relevance of activated beta 1 integrins in mercury-induced nephritis. Journal of the American Society of Nephrology 11: (6) 1075-1084 JUN 2000. PVG: Hughes J, Nangaku M, Alpers CE, Shankland SJ, Couser WG, Johnson RJ. C5b-9 membrane attack complex mediates endothelial cell apoptosis in experimental glomerulonephritis. American Journal of Physiology-Renal Physiology 278: (5) F747-F757 MAY 2000. BN: White KL, David DW, Butterworth LF, Klykken PC. Assessment of autoimmunity-inducing potential using the Brown Norway rat challenge model. Toxicology Letters 112: 443-451 MAR 15 2000. Wistar: Gomez-Guerrero C, Duque N, Casado MT, Pastor C, Blanco J, Mampaso F, Vivanco F, Egido J. Administration of IgG Fc fragments prevents glomerular injury in experimental immune complex nephritis. Journal of Immunology 164: (4) 2092-2101 FEB 15 2000. Lewis: Luca ME, Paul LC, van der Wal AM, Bruijn JA, de Heer E. Treatment with mycophenolate mofetil attenuates the development of Heymann nephritis. Experimental Nephrology 8: (2) 77-83 MAR-APR 2000. WKY: Reynolds J, Tam FWK, Chandraker A, Smith J, Karkar AM, Cross J, Peach R, Sayegh MH, Pusey CD. CD28-B7 blockade prevents the development of experimental autoimmune glomerulonephritis. Journal of Clinical Investigation 105: (5) 643-651 MAR 2000. Lewis: Oleinikov AV, Feliz BJ, Makker SP. A small N-terminal 60-kD fragment of gp600 (Megalin), the major autoantigen of active Heymann nephritis, can induce a full-blown disease. Journal of the American Society of Nephrology 11: (1) 57-64 JAN 2000. WKY: Tam FWK, Smith J, Agarwal S, Karkar AM, Morel D, Thompson EM, Pusey CD. Type IV phosphodiesterase inhibitor is effective in prevention and treatment of experimental crescentic glomerulonephritis. Nephron 84: (1) 58-66 JAN 2000. Lewis: Jayne D. Non-transplant uses of mycophenolate mofetil. Current Opinion in Nephrology and Hypertension 8: (5) 563-567 SEP 1999. WKY: Tam FWK, Smith J, Morel D, Karkar AM, Thompson EM, Cook HT, Pusey CD. Development of scarring and renal failure in a rat model of crescentic Glomerulonephritis. Nephrology Dialysis Transplantation 14: (7) 1658-1666 JUL 1999. WKY: Allen AR, McHale J, Smith J, Cook HT, Karkar A, Haskard DO, Lobb RR, Pusey CD. Endothelial expression of VCAM-1 in experimental crescentic nephritis and effect of antibodies to very late antigen-4 or VCAM-1 on glomerular injury. Journal of Immunology 162: (9) 5519-5527 MAY 1 1999. BN: Nakahama H, Obata K, Sugita M, Horio M, Oka K, Moriyama T. Effect of FK 506 in the treatment of autoimmune glomerulonephritis in brown Norway rats. Nephron 81: (4) 421-427 APR 1999. BN: Nakahama H, Obata K, Matsuyama T, Sugita M, Horio M, Oka K, Moriyama T. Effect of a novel immunosuppressant, FK 506, on autoimmune glomerulonephritis in Brown Norway rats. Nephron 81: (2) 215-220 FEB 1999. Wistar Kyoto, Sprague Dawley: Kanno K, Okumura F, Toriumi W, Ishiyama N, Nishiyama S, Naito K. Nephrotoxic serum-induced nephritis in Wistar-Kyoto rats: A model to evaluate antinephritic agents. Japanese Journal of Pharmacology 77: (2) 129-135 JUN 1998. BN: Druet E, Praddaude F, Druet P, Dietrich G. Non-immunoglobulin serum proteins prevent the binding of IgG from normal rats and from rats with Th2-mediated autoimmune glomerulonephritis to various autoantigens including glomerular antigens. European Journal of Immunology 28: (1) 183-192 JAN 1998. Wistar Kyoto substrains, BN: Reynolds J, Mavromatidis K, Cashman SJ, Evans DJ, Pusey CD. Experimental autoimmune glomerulonephritis (EAG) induced by homologous and heterologous glomerular basement membrane in two substrains of Wistar-Kyoto rat. Nephrology Dialysis Transplantation 13: (1) 44-52 JAN 1998. |
||||||||||
|
Experimental Autoimmune Cystitis (EAC) Lewis: Mitra S, Dagher A, Kage R, Dagher RK, Luber-Narod J. Experimental autoimmune cystitis: further characterization and serum autoantibodies. Urological Research 27: (5) 351-356 OCT 1999. Lewis: Luber-Narod J, Austin-Ritchie T, Hollins C, Menon M, Malhotra RK, Baker S, Carraway RE. Role of substance P in several models of bladder inflammation. Urological Research 25: (6) 395-399 DEC 1997. Lewis: LuberNarod J, AustinRitchie T, Banner B, Hollins C, Maramag C, Price H, Menon M. Experimental autoimmune cystitis in the Lewis rat: A potential animal model for interstitial cystitis. Urological Research 24: (6) 367-373 DEC 1996. |
||||||||||
|
Experimental Autoimmune Myositis (EAM) Lewis: Schneider C, Matsumoto Y, Kohyama K, Toyka KV, Hartung HP, Gold R. Experimental autoimmune myositis in the Lewis rat: lack of spontaneous T-cell apoptosis and therapeutic response to glucocorticosteroid application. Journal of Neuroimmunology 107: (1) 83-87 JUL 10 2000. Lewis, WF: Wang HB, Shi FD, Li HL, van der Meide PH, Ljunggren HG, Link H. Role for interferon-gamma in rat strains with different susceptibility to experimental autoimmune myasthenia gravis. Clinical Immunology 95: (2) 156-162 MAY 2000. Lewis: Kitabayashi H, Isobe M, Watanabe N, Suzuki J, Yazaki Y, Sekiguchi M. FTY720 prevents development of experimental autoimmune myocarditis through reduction of circulating lymphocytes. Journal of Cardiovascular Pharmacology 35: (3) 410-416 MAR 2000. Lewis: Araga S, Xu LK, Nakashima K, Villain M, Blalock JE. A peptide vaccine that prevents experimental autoimmune myasthenia gravis by specifically blocking T cell help. FASEB Journal 14: (1) 185-196 JAN 2000. Lewis: Komai K, Iwasa K, Takamori M. Calcium channel peptide can cause an autoimmune-mediated model of Lambert-Eaton myasthenic syndrome in rats. Journal of the Neurological Sciences 166: (2) 126-130 JUL 1 1999. Lewis: Kohyama K, Matsumoto Y. C-protein in the skeletal muscle induces severe autoimmune polymyositis in Lewis rats. Journal of neuroimmunology 98: (2) 130-135 AUG 3 1999. Tsukagoshi H, Morita T, Takahashi K, Kunimoto F, Goto F. Cecal ligation and puncture peritonitis model shows decreased nicotinic acetylcholine receptor numbers in rat muscle - Immunopathologic mechanisms? Anesthesiology 91: (2) 448-460 AUG 1999. |
||||||||||
|
Diabetes BB, Wistar-Furth: Tori M, Ito T, Kitagawa-Sakakida S, Nozawa M, Matsuda H, Shirakura R. Importance of donor-derived lymphocytes in the protection of pancreaticoduodenal or islet grafts from recurrent autoimmunity: A role for RT6(+)NKR-P1(+) T cells. Transplantation 70: (1) 32-38 JUL 15 2000. BB-DP, LEW1.WR1, PVG.RT1u, PVG.R8, PVG.R23, WAG, WAG-rnu, WF, LOU, PVG.RT1c: Ellerman KE, Like AA. Susceptibility to diabetes is widely distributed in normal class IIu haplotype rats. Diabetologia 43: (7) 890-898 JUL 2000. BB: Larsen B, Liu HG, Jackman S, Driscoll H. Effect of gliotoxin on development of diabetes mellitus in diabetes-prone BB/Wor rats. Annals of Clinical and Laboratory Science 30: (1) 99-106 JAN 2000. WF, BN, ACI: Ali A, Garrovillo M, Jin MX, Hardy MA, Oluwole SF. Major histocompatibility complex class I peptide-pulsed host dendritic cells induce antigen-specific acquired thymic tolerance to islet cells. Transplantation 69: (2) 221-226 JAN 27 200. BBDP: Ellis EA, Guberski DL, Somogyi-Mann M, Grant MB. Increased H2O2, vascular endothelial growth factor and receptors in the retina of the BBZ/WOR diabetic rat. Free Radical Biology and Medicine 28: (1) 91-101 JAN 2000. BB: Trudeau JD, Dutz JP, Arany E, Hill DJ, Fieldus WE, Finegood DT. Neonatal beta-cell apoptosis - A trigger for autoimmune diabetes? Diabetes 49: (1) 1-7 JAN 2000. LEW.1AR1: Prokop CM, Wedekind D, Lenzen S, Tiedge M, Elsner M, Lortz S, Jorns A, Kloppel G, Hedrich HJ. A new rat model for insulin-dependent diabetes mellitus (IDDM). Journal of Experimental Animal Science 41: (1-2) 14-18 MAR 2000. BB, Wistar: Thliveris JA, HayGlass KT, Manchur D, Rector E, Begleiter A, Johnston JB. Functional status of the immune system after chronic administration of 2 '-deoxycoformycin in the BB rat. Histology and Histopathology 15: (1) 21-27 JAN 2000. BB: Song HY, Abad MM, Mahoney CP, McEvoy RC. Human insulin B chain but not A chain decreases the rate of diabetes in BB rats. Diabetes Research and Clinical Practice 46: (2) 109-114 NOV 1999. BB: Iwakoshi NN, Greiner DL, Rossini AA, Mordes JP. Diabetes prone BB rats are severely deficient in natural killer T cells. Autoimmunity 31: (1) 1-14 1999. DPBB, DRBB, WF: Martin AM, Maxson MN, Leif J, Mordes JP, Greiner DL, Blankenhorn EP. Diabetes-prone and diabetes-resistant BB rats share a common major diabetes susceptibility locus, iddm4 - Additional evidence for a "universal autoimmunity locus" on rat chromosome 4. Diabetes 48: (11) 2138-2144 NOV 1999. BB: Bieg S, Simonson W, Ellefsen K, Lernmark A. Rel B is an early marker of autoimmune islet inflammation in the BioBreeding (BB) rat. Pancreas 20: (1) 47-54 JAN 2000. BB: Klaff LS, G Koike, J Jiang, Y Wang, S Bieg, A Pettersson, E Lander, H Jacob, A Lernmark. BB rat diabetes susceptibility and body weight regulation genes co-localize on Chromosome 2. Mammalian Genome 10 (1999): 883-887. BB: Moore JK, Gold DP, Dreskin SC, Lernmark A, Bellgrau D. A diabetogenic gene prevents T cells from receiving costimulatory signals. Cellular Immunology 194: (1) 90-97 MAY 25 1999. BB: Meddings JB, Jarand J, Urbanski SJ, Hardin J, Gall DG. Increased gastrointestinal permeability is an early lesion in the spontaneously diabetic BB rat. American Journal of Physiology-gastrointestinal and Liver Physiology 39: (4) G951-G957 APR 1999. BB-DP, Wistar: Delemarre RGA, Simons PJ, de Heer HJ, Drexhage HA. Signs of immaturity of splenic dendritic cells from the autoimmune prone biobreeding rat: Consequences for the in vitro expansion of regulator and effector T cells. Journal of Immunology 162: (3) 1795-1801 FEB 1 1999. BB-DP, BB-DR, WF: Martin AM, Blankenhorn EP, Maxson MN, Zhao M, Leif J, Mordes JP, Greiner DL. Non-major histocompatibility complex-linked diabetes susceptibility loci on chromosomes 4 and 13 in a backcross of the DP-BB/Wor rat to the WF rat. Diabetes 48: (1) 50-58 JAN 1999. BB-DP: Bone AJ, Hitchcock PR, Gwilliam DJ, Cunningham JM, Barley J. Insulitis and mechanisms of disease resistance: studies in an animal model of insulin dependent diabetes mellitus. Journal of Molecular Medicine-JMM 77: (1) 57-61 JAN 1999. Long-Evans Toskushima Lean, DP and DR sublines: Komeda K, Noda M, Terao K, Kuzuya N, Kanazawa M, Kanazawa Y. Establishment of two substrains, diabetes-prone and non-diabetic, from Long-Evans Tokushima Lean (LETL) rats. Endocrine Journal 45: (6) 737-744 DEC 1998. BB-DP, BB-DR: Iwakoshi NN, Goldschneider I, Tausche F, Mordes JP, Rossini AA, Greiner DL. High frequency apoptosis of recent thymic emigrants in the liver of lymphopenic diabetes-prone BioBreeding rats. Journal of Immunology 160: (12) 5838-5850 JUN 15 1998. BB: Nguyen C, Pan JQ, Charles MA. Preclinical studies of glimepiride. Drugs of Today 34: (5) 391-400 MAY 1998. BB-DP, Wistar: Simons PJ, Delemarre FGA, Jeucken PHM, Drexhage HA. Pre-autoimmune thyroid abnormalities in the biobreeding diabetes-prone (BB-DP) rat: a possible relation with the intrathyroid accumulation of dendritic cells and the initiation of the thyroid autoimmune response. Journal of Endocrinology 157: (1) 43-51 APR 1998. BB: Bieg S, Koike G, Jiang J, Klaff L, Pettersson A, MacMurray AJ, Jacob HJ, Lander ES, Lernmark A. Genetic isolation of iddm 1 on chromosome 4 in the BioBreeding (BB) rat. Mammalian Genome 9: (4) 324-326 APR 1998. BB-DP: Sobel DO, Newsome J. Gamma interferon prevents diabetes in the BB rat. Clinical and Diagnostic Laboratory Immunology 4: (6) 764-768 NOV 1997. Long-Evans Toskushima Lean, Long-Evans Tokushima Otsuka, Tester Moriyama, Komeda-DP, BN: Yokoi N, Kanazawa M, Kitada K, Tanaka A, Kanazawa Y, Suda S, Ito H, Serikawa T, Komeda K. A non-MHC locus essential for autoimmune type I diabetes in the Komeda diabetes-prone rat. Journal of Clinical Investigation 100: (8) 2015-2021 OCT 15 1997. BB-DP: Greiner DL, Malkani S, Kanaitsuka T, Bortell R, Doukas J, Rigby M, Whalen B, Stevens LA, Moss J, Mordes JP, Rossini AA. The T cell marker RT6 in a rat model of autoimmune diabetes. Advances in Experimental Medicine and Biology 419: 209-216 1997. BB-DP, BN, Lewis: Kosuda LL, Greiner DL, Bigazzi PE. Effects of HgCl2 on the expression of autoimmune responses and disease in diabetes-prone (DP) BB rats. Autoimmunity 26: (3) 173-187 1997. |
||||||||||
|
Arthritis Lewis: Paul AGA, van der Zee R, Taams LS, van Eden W. A self-hsp60 peptide acts as a partial agonist inducing expression of B7-2 on mycobacterial hsp60-specific T cells: a possible mechanism for inhibitory T cell regulation of adjuvant arthritis? International Immunology 12: (7) 1041-1050 JUL 2000. Wistar: Chover-Gonzalez AJ, Jessop DS, Tejedor-Real P, Gibert-Rahola J, Harbuz MS. Onset and severity of inflammation in rats exposed to the learned helplessness paradigm. Rheumatology 39: (7) 764-771 JUL 2000. Holtzman: Francischi JN, Yokoro CM, Poole S, Tafuri WL, Cunha FQ, Teixeira MM. Anti-inflammatory and analgesic effects of the phosphodiesterase 4 inhibitor rolipram in a rat model of arthritis. European Journal of Pharmacology 399: (2-3) 243-249 JUL 7 2000. Ayer LM, Issekutz AC, Waterhouse CCM, Stadnyk AW. Cytokine mRNA in the joints and draining lymph nodes of rats with adjuvant arthritis and effects of cyclosporin A. Inflammation 24: (5) 447-461 OCT 2000. Lewis: Eberini I, Agnello D, Miller I, Villa P, Fratelli M, Ghezzi P, Gemeiner M, Chan J, Aebersold R, Gianazza E. Proteins of rat serum V: Adjuvant arthritis and its modulation by nonsteroidal anti-inflammatory drugs. Electrophoresis 21: (11) 2170-2179 JUN 2000. Lewis: Szekanecz Z, Halloran MM, Volin MV, Woods JM, Strieter RM, Haines GK, Kunkel SL, Burdick MD, Koch AE. Temporal expression of inflammatory cytokines and chemokines in rat adjuvant-induced arthritis. Arthritis and Rheumatism 43: (6) 1266-1277 JUN 2000. DA, LEW.1AV1: Jansson AM, Lorentzen JC, Bucht A. CD8(+) cells suppress oil-induced arthritis. Clinical and Experimental Immunology 120: (3) 532-536 JUN 2000. DA, DA.1H, LEW.1AV1, LEW.1F, PVG.1AV1, DALEW.1AV1F1: Carlson BC, Jansson AM, Larsson A, Bucht A, Lorentzen JC. The endogenous adjuvant squalene can induce a chronic T-cell-mediated arthritis in rats. American Journal of Pathology 156: (6) 2057-2065 JUN 2000. Lewis: Simelyte E, Rimpilainen M, Lehtonen L, Zhang X, Toivanen P. Bacterial cell wall-induced arthritis: Chemical composition and tissue distribution of four Lactobacillus strains. Infection and Immunity 68: (6) 3535-3540 JUN 2000. DA, BN: Griffiths MM, Wang JP, Joe B, Dracheva S, Kawahito Y, Shepard JS, Reese VA, McCall-Vining S, Hashiramoto A, Cannon GW, Remmers EF, Wilder RL. Identification of four new quantitative trait loci regulating arthritis severity and one new quantitative trait locus regulating autoantibody production in rats with collagen-induced arthritis. Arthritis and Rheumatism 43: (6) 1278-1289 JUN 2000. Lewis: Cicala C, Ianaro A, Fiorucci S, Calignano A, Bucci M, Gerli R, Santucci L, Wallace JL, Cirino G. NO-naproxen modulates inflammation, nociception and downregulates T cell response in rat Freund's adjuvant arthritis. British Journal of Pharmacology 130: (6) 1399-1405 JUL 2000. Lewis: Williams A, Goodfellow R, Topley N, Amos N, Williams B. The suppression of rat collagen-induced arthritis and inhibition of macrophage derived mediator release by liposomal methotrexate formulations. Inflammation Research 49: (4) 155-161 APR 2000. Lewis: Zhang X, Rimpilainen M, Simelyte E, Toivanen P. What determines arthritogenicity of bacterial cell wall? A study on Eubacterium cell wall-induced arthritis. Rheumatology 39: (3) 274-282 MAR 2000. Sprague-Dawley: Leech M, Metz C, Bucala R, Morand EF. Regulation of macrophage migration inhibitory factor by endogenous glucocorticoids in rat adjuvant-induced arthritis. Arthritis and Rheumatism 43: (4) 827-833 APR 2000. Lewis, Sprague-Dawley: Matsuura M, Imayoshi T, Okumoto T. Effect of FTY720, a novel immunosuppressant, on adjuvant- and collagen-induced arthritis in rats. International Journal of Immunopharmacology 22: (4) 323-331 APR 2000. Lewis: Yamada R, Sano H, Hla T, Hashiramoto A, Kawahito Y, Mukai S, Kohno M, Tsubouchi Y, Inoue M, Komatsu A, Inoue K, Kondo M. Selective inhibition of cyclooxygenase-2 with antisense oligodeoxynucleotide restricts induction of rat adjuvant-induced arthritis. Biochemical and Biophysical Research Communications 269: (2) 415-421 MAR 16 2000. Lewis: Jurcovicova J, Svik K, Rovensky J, Stancikova M, Zorad S, Konecna I, Holecek V, Trefil L, Racek J, Rokyta R. Suppression of adjuvant arthritis in rats with chronic bromocriptine treatment does not prevent associated oxidative stress. International Journal of Immunopathology and Pharmacology 13: (1) 31-37 JAN-APR 2000. Sprague Dawley: Hansra P, Moran EL, Fornasier VL, Bogoch ER. Carrageenan-induced arthritis in the rat. Inflammation 24: (2) 141-155 APR 2000. Lewis: Cuzzocrea S, McDonald MC, Mota-Filipe H, Mazzon E, Costantino G, Britti D, Mazzullo G, Caputi AP, Thiemermann C. Beneficial effects of tempol, a membrane-permeable radical scavenger, in a rodent model of collagen-induced arthritis. Arthritis and Rheumatism 43: (2) 320-328 FEB 2000. Lewis: Goodfellow RM, Williams AS, Levin JL, Williams BD, Morgan BP. Soluble complement receptor one (sCR1) inhibits the development and progression of rat collagen-induced arthritis. Clinical and Experimental Immunology 119: (1) 210-216 JAN 2000. Lewis: Volker DH, FitzGerald PEB, Garg ML. The eicosapentaenoic to docosahexaenoic acid ratio of diets affects the pathogenesis of arthritis in Lew/SSN rats. Journal of Nutrition 130: (3) 559-565 MAR 2000. DA, E3: Holmdahl R, Vingsbo-Lundberg C, Nordquist N, Olofsson P, Sundvall M, Saxne T, Pettersson U. Genetic control of arthritis in rats. Journal of Experimental Animal Science 41: (1-2) 7-13 MAR 2000. Lewis, Sprague Dawley: Chover-Gonzalez AJ, Harbuz MS, Tejedor-Real P, Gibert-Rahola J, Larsen PJ, Jessop DS. Effects of stress on susceptibility and severity of inflammation in adjuvant-induced arthritis. Neuroendocrine Immune Basis of the Rheumatic Diseases, NY Acad Sci 876: 276-286 1999. Lewis: Hansson AS, Heinegard D, Holmdahl R. A new animal model for relapsing polychondritis, induced by cartilage matrix protein (matrilin-1). Journal of Clinical Investigation 104: (5) 589-598 SEP 1999. DA: Voll RE, Mikulowska A, Kalden JR, Holmdahl R. Amelioration of type II collagen induced arthritis in rats by treatment with sodium diethyldithiocarbamate. Journal of Rheumatology 26: (6) 1352-1358 JUN 1999. Lewis: Stohr T, Szuran T, Pliska V, Feldon J. Behavioural and hormonal differences between two Lewis rat lines. Behavioural Brain Research 101: (2) 163-172 JUN 1999. DA, LEW.AV1: Lorentzen JC. Identification of arthritogenic adjuvants of self and foreign origin. Scandinavian Journal of Immunology 49: (1) 45-50 JAN 1999. Lewis: ten Bokum AMC, Lichtenauer-Kaligis EGR, Melief MJ, van Koetsveld PM, Bruns C, van Hagen PM, Hofland LJ, Lamberts SWJ, Hazenberg MP. Somatostatin receptor subtype expression in cells of the rat immune system during adjuvant arthritis. Journal of Endocrinology 161: (1) 167-175 APR 1999. Sprague Dawley: Pan RY, Xiao X, Chen SL, Li J, Lin LC, Wang HJ, Tsao YP. Disease-inducible transgene expression from a recombinant adeno-associated virus vector in a rat arthritis model. Journal of Virology 73: (4) 3410-3417 APR 1999. DA, ACI: Gulko PS, Kawahito Y, Remmers EF, Reese VR, Wang JP, Dracheva SV, Ge L, Longman RE, Shepard JS, Cannon GW, Sawitzke AD, Wilder RL, Griffiths MM. Identification of a new non-major histocompatibility complex genetic locus on chromosome 2 that controls disease severity in collagen-induced arthritis in rats. Arthritis and Rheumatism 41: (12) 2122-2131 DEC 1998. HLA-B27 transgenic: Onderdonk AB, Richardson JA, Hammer RE, Taurog JD. Correlation of cecal microflora of HLA-B27 transgenic rats with inflammatory bowel disease. Infection and Immunity 66: (12) 6022-6023 DEC 1998. DA, Fisher: Kawahito Y, Cannon GW, Gulko PS, Remmers EF, Longman RE, Reese VR, Wang JP, Griffiths MM, Wilder RL. Localization of quantitative trait loci regulating adjuvant-induced arthritis in rats: Evidence for genetic factors common to multiple autoimmune diseases. Journal of Immunology 161: (8) 4411-4419 OCT 15 1998. HLA-B27 transgenic: Taurog JD. Arthritis in HLA-B27 transgenic animals. American Journal of the Medical Sciences 316: (4) 250-256 OCT 1998. HLA-B27 and NP1 transgenic: Zhou M, Sayad A, Simmons WA, Jones RC, Maika SD, Satumtira N, Dorris ML, Gaskell SJ, Bordoli RS, Sartor RB, Slaughter CA, Richardson JA, Hammer RE, Taurog JD. The specificity of peptides bound to human histocompatibility leukocyte antigen (HLA)-B27 influences the prevalence of arthritis in HLA-B27 transgenic rats. Journal of Experimental Medicine 188: (5) 877-886 SEP 7 1998. Lewis: Ohta Y, Fukuda S, Makino H. Reduction of disease causative T-cells in experimental autoimmune disease models by a new antirheumatic drug, TAK-603. Immunopharmacology 37: (2-3) 167-174 OCT 1997. |
||||||||||
|
Alopecia areata (AA) McElwee KJ, Tobin DJ, Bystryn JC, King LE, Sundberg JP. Alopecia areata: an autoimmune disease? Experimental Dermatology 8: (5) 371-379 OCT 1999. DEBR: McElwee KJ, Spiers EM, Oliver RF. Partial restoration of hair growth in the DEBR model for alopecia areata after in vivo depletion of CD4+ T cells. British Journal of Dermatology 140: (3) 432-437 MAR 1999. DEBR: McElwee KJ, Spiers EM, Oliver RF. Partial restoration of hair growth in the DEBR model for alopecia areata after in vivo depletion of CD4+ T cells. British Journal of Dermatology 140: (3) 432-437 MAR 1999. |
||||||||||
| Project Description | Current Inventory | Related Links | Autoimmune References | Home Page | ||||||